The effects of early treatment of hereditary tyrosinemia type i in infancy by orthotopic liver transplantation

M. Wayne Flye, Caroline A. Riely, Bryan E. Hainline, Shigeru Sassa, Richard J. Gusberg, Karin J. Blakemore, Kenneth W. Barwick, Arthur L. Horwich

Research output: Contribution to journalArticle

Abstract

Two infants with hereditary tyrosinemia secondary to fumarylacetoacetate hydrolase (FAH) deficiency underwent orthotopic liver transplantation at 14 and 16 weeks of age due to poor clinical and biochemical response to medical therapy. Prompt clearance of abnormal metabolites with improved mental alertness and appetite occurred with minimal perioperative complications. Both infants tolerated rapid institution of normal diets and have shown progressive growth and development in the first 36 months after transplantation. Early liver transplantation should be considered as an option for infants with certain inherited metabolic disorders with poor prognosis, such as tyrosinemia type I, who fail to respond to medical therapy.

Original languageEnglish (US)
Pages (from-to)916-921
Number of pages6
JournalTransplantation
Volume49
Issue number5
StatePublished - May 1990
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'The effects of early treatment of hereditary tyrosinemia type i in infancy by orthotopic liver transplantation'. Together they form a unique fingerprint.

  • Cite this

    Wayne Flye, M., Riely, C. A., Hainline, B. E., Sassa, S., Gusberg, R. J., Blakemore, K. J., Barwick, K. W., & Horwich, A. L. (1990). The effects of early treatment of hereditary tyrosinemia type i in infancy by orthotopic liver transplantation. Transplantation, 49(5), 916-921.